By Professor Glenda Halliday

Journal articles

Naaldijk Y; Fernández B; Fasiczka R; Fdez E; Leghay C; Croitoru I; Kwok JB; Boulesnane Y; Vizeneux A; Mutez E; Calvez C; Destée A; Taymans JM; Aragon AV; Yarza AB; Padmanabhan S; Delgado M; Alcalay RN; Chatterton Z; Dzamko N; Halliday G; Ruiz-Martínez J; Chartier-Harlin MC; Hilfiker S, 2024, 'A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells', npj Parkinson's Disease, 10, http://dx.doi.org/10.1038/s41531-023-00624-8

Fu YH; Pickford R; Galper J; Phan K; Wu P; Li H; Kim YB; Dzamko N; Halliday GM; Kim WS, 2024, 'A protective role of ABCA5 in response to elevated sphingomyelin levels in Parkinson’s disease', npj Parkinson's Disease, 10, http://dx.doi.org/10.1038/s41531-024-00632-2

Luo H; Gustavsson EK; Macpherson H; Dominik N; Zhelcheska K; Montgomery K; Anderson C; Yau WY; Efthymiou S; Turner C; DeTure M; Dickson DW; Josephs KA; Revesz T; Lashley T; Halliday G; Rowe DB; McCann E; Blair I; Lees AJ; Tienari PJ; Suomalainen A; Molina-Porcel L; Kovacs GG; Gelpi E; Hardy J; Haltia MJ; Tucci A; Jaunmuktane Z; Ryten M; Houlden H; Chen Z, 2024, 'Letter to the editor on: Hornerin deposits in neuronal intranuclear inclusion disease: direct identification of proteins with compositionally biased regions in inclusions by Park et al. (2022)', Acta Neuropathologica Communications, 12, http://dx.doi.org/10.1186/s40478-023-01706-7

Galper J; Mori G; McDonald G; Ahmadi Rastegar D; Pickford R; Lewis SJG; Halliday GM; Kim WS; Dzamko N, 2024, 'Prediction of motor and non-motor Parkinson’s disease symptoms using serum lipidomics and machine learning: a 2-year study', npj Parkinson's Disease, 10, http://dx.doi.org/10.1038/s41531-024-00741-y

Ndayisaba A; Halliday GM; Khurana V, 2024, 'Multiple System Atrophy: Pathology, Pathogenesis, and Path Forward.', Annu Rev Pathol, http://dx.doi.org/10.1146/annurev-pathmechdis-051122-104528

Burré J; Edwards RH; Halliday G; Lang AE; Lashuel HA; Melki R; Murayama S; Outeiro TF; Papa SM; Stefanis L; Woerman AL; Surmeier DJ; Kalia LV; Takahashi R; Olsen A; Surmeier DJ; Bayram E; Chaing HL; Lee JY; Peall K; Lohmann K; Zeuner K; Kalia L; Cornejo-Olivas M; Calabresi P; Takahashi R; Przedborski S, 2024, 'Research Priorities on the Role of α-Synuclein in Parkinson's Disease Pathogenesis', Movement Disorders, 39, pp. 1663 - 1678, http://dx.doi.org/10.1002/mds.29897

Lam I; Ndayisaba A; Lewis AJ; Fu YH; Sagredo GT; Kuzkina A; Zaccagnini L; Celikag M; Sandoe J; Sanz RL; Vahdatshoar A; Martin TD; Morshed N; Ichihashi T; Tripathi A; Ramalingam N; Oettgen-Suazo C; Bartels T; Boussouf M; Schäbinger M; Hallacli E; Jiang X; Verma A; Tea C; Wang Z; Hakozaki H; Yu X; Hyles K; Park C; Wang X; Theunissen TW; Wang H; Jaenisch R; Lindquist S; Stevens B; Stefanova N; Wenning G; van de Berg WDJ; Luk KC; Sanchez-Pernaute R; Gómez-Esteban JC; Felsky D; Kiyota Y; Sahni N; Yi SS; Chung CY; Stahlberg H; Ferrer I; Schöneberg J; Elledge SJ; Dettmer U; Halliday GM; Bartels T; Khurana V, 2024, 'Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions', Neuron, 112, pp. 2886 - 2909.e16, http://dx.doi.org/10.1016/j.neuron.2024.06.002

Sagredo GT; Tanglay O; Shahdadpuri S; Fu YH; Halliday GM, 2024, '⍺-Synuclein levels in Parkinson's disease – Cell types and forms that contribute to pathogenesis', Experimental Neurology, 379, http://dx.doi.org/10.1016/j.expneurol.2024.114887

Carroll J; McCann H; Halliday GM; Kwok JB; Dobson-Stone C; Shepherd CE, 2024, 'Poly-GA immunohistochemistry is a reliable tool for detecting C9orf72 hexanucleotide repeat expansions', Brain Pathology, 34, http://dx.doi.org/10.1111/bpa.13216

Clarke AJ; Brodtmann A; Irish M; Mowszowski L; Radford K; Naismith SL; Mok VCT; Kiernan MC; Halliday GM; Ahmed RM, 2024, 'Risk factors for the neurodegenerative dementias in the Western Pacific region', The Lancet Regional Health - Western Pacific, 50, http://dx.doi.org/10.1016/j.lanwpc.2024.101051

Liao S-C; Kano K; Phanse S; Nguyen M; Margolis E; Fu Y; Meng J; Moutaoufik MT; Chatterton Z; Aoki H; Simms J; Hsieh I; Suteja F; Sei Y; Huang EJ; McAvoy K; Manfredi G; Halliday G; Babu M; Nakamura K, 2024, 'CHCHD2 mutant mice display mitochondrial protein accumulation and disrupted energy metabolism.', bioRxiv, http://dx.doi.org/10.1101/2024.08.30.610586

Manzoni C; Kia DA; Ferrari R; Leonenko G; Costa B; Saba V; Jabbari E; Tan MM; Albani D; Alvarez V; Alvarez I; Andreassen OA; Angiolillo A; Arighi A; Baker M; Benussi L; Bessi V; Binetti G; Blackburn DJ; Boada M; Boeve BF; Borrego-Ecija S; Borroni B; Bråthen G; Brooks WS; Bruni AC; Caroppo P; Bandres-Ciga S; Clarimon J; Colao R; Cruchaga C; Danek A; de Boer SC; de Rojas I; di Costanzo A; Dickson DW; Diehl-Schmid J; Dobson-Stone C; Dols-Icardo O; Donizetti A; Dopper E; Durante E; Ferrari C; Forloni G; Frangipane F; Fratiglioni L; Kramberger MG; Galimberti D; Gallucci M; García-González P; Ghidoni R; Giaccone G; Graff C; Graff-Radford NR; Grafman J; Halliday GM; Hernandez DG; Hjermind LE; Hodges JR; Holloway G; Huey ED; Illán-Gala I; Josephs KA; Knopman DS; Kristiansen M; Kwok JB; Leber I; Leonard HL; Libri I; Lleo A; Mackenzie IR; Madhan GK; Maletta R; Marquié M; Maver A; Menendez-Gonzalez M; Milan G; Miller BL; Morris CM; Morris HR; Nacmias B; Newton J; Nielsen JE; Nilsson C; Novelli V; Padovani A; Pal S; Pasquier F; Pastor P; Perneczky R; Peterlin B; Petersen RC; Piguet O; Pijnenburg YA; Puca AA; Rademakers R; Rainero I; Reus LM; Richardson AM; Riemenschneider M, 2024, 'Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia', American Journal of Human Genetics, 111, pp. 1316 - 1329, http://dx.doi.org/10.1016/j.ajhg.2024.05.017

Pottier C; Küçükali F; Baker M; Batzler A; Jenkins GD; van Blitterswijk M; Vicente CT; De Coster W; Wynants S; Van de Walle P; Ross OA; Murray ME; Faura J; Haggarty SJ; van Rooij JG; Mol MO; Hsiung G-YR; Graff C; Öijerstedt L; Neumann M; Asmann Y; McDonnell SK; Baheti S; Josephs KA; Whitwell JL; Bieniek KF; Forsberg L; Heuer H; Lago AL; Geier EG; Yokoyama JS; Oddi AP; Flanagan M; Mao Q; Hodges JR; Kwok JB; Domoto-Reilly K; Synofzik M; Wilke C; Onyike C; Dickerson BC; Evers BM; Dugger BN; Munoz DG; Keith J; Zinman L; Rogaeva E; Suh E; Gefen T; Geula C; Weintraub S; Diehl-Schmid J; Farlow MR; Edbauer D; Woodruff BK; Caselli RJ; Donker Kaat LL; Huey ED; Reiman EM; Mead S; King A; Roeber S; Nana AL; Ertekin-Taner N; Knopman DS; Petersen RC; Petrucelli L; Uitti RJ; Wszolek ZK; Ramos EM; Grinberg LT; Gorno Tempini ML; Rosen HJ; Spina S; Piguet O; Grossman M; Trojanowski JQ; Keene DC; Lee-Way J; Prudlo J; Geschwind DH; Rissman RA; Cruchaga C; Ghetti B; Halliday GM; Beach TG; Serrano GE; Arzberger T; Herms J; Boxer AL; Honig LS; Vonsattel JP; Lopez OL; Kofler J; White CL; Gearing M; Glass J; Rohrer JD; Irwin DJ; Lee EB; Van Deerlin V; Castellani R; Mesulam MM; Tartaglia MC; Finger EC; Troakes C; Al-Sarraj S; Miller BL; Seelaar H; Graff-Radford NR; Boeve BF; Mackenzie IR; van Swieten JC; Seeley WW; Sleegers K; Dickson DW; Biernacka JM; Rademakers R, 2024, 'Deciphering Distinct Genetic Risk Factors for FTLD-TDP Pathological Subtypes via Whole-Genome Sequencing.', medRxiv, http://dx.doi.org/10.1101/2024.06.24.24309088

Valentino RR; Scotton WJ; Roemer SF; Lashley T; Heckman MG; Shoai M; Martinez-Carrasco A; Tamvaka N; Walton RL; Baker MC; Macpherson HL; Real R; Soto-Beasley AI; Mok K; Revesz T; Christopher EA; DeTure M; Seeley WW; Lee EB; Frosch MP; Molina-Porcel L; Gefen T; Redding-Ochoa J; Ghetti B; Robinson AC; Kobylecki C; Rowe JB; Beach TG; Teich AF; Keith JL; Bodi I; Halliday GM; Gearing M; Arzberger T; Morris CM; White CL; Mechawar N; Boluda S; MacKenzie IR; McLean C; Cykowski MD; Wang SHJ; Graff C; Nagra RM; Kovacs GG; Giaccone G; Neumann M; Ang LC; Carvalho A; Morris HR; Rademakers R; Hardy JA; Dickson DW; Rohrer JD; Ross OA; Warner TT; Jaunmuktane Z; Boeve BF; Duara R; Graff-Radford NR; Josephs KA; Knopman DS; Koga S; Murray ME; Lyons KE; Pahwa R; Petersen RC; Whitwell JL; Grinberg LT; Miller B; Schlereth A; Spina S; Grossman M; Irwin DJ; Suh ER; Trojanowski JQ; Van Deerlin VM; Wolk DA; Connors TR; Dooley PM; Oakley DH; Aldecoa I; Balasa M; Gelpi E; Borrego-Écija S; Gascon-Bayarri J; Sánchez-Valle R; Sanz-Cartagena P; Piñol-Ripoll G; Bigio EH; Flanagan ME; Rogalski EJ; Weintraub S; Schneider JA; Peng L; Zhu X; Chang K; Troncoso JC; Prokop S; Newell KL, 2024, 'MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study', The Lancet Neurology, 23, pp. 487 - 499, http://dx.doi.org/10.1016/S1474-4422(24)00083-8

Lok HC; Halliday GM; Kim WS, 2024, 'ATP-binding cassette transporters as possible targets for the intervention of neurodegenerative diseases', Neural Regeneration Research, 19, pp. 721 - 722, http://dx.doi.org/10.4103/1673-5374.382239

Marras C; Fereshtehnejad SM; Berg D; Bohnen NI; Dujardin K; Erro R; Espay AJ; Halliday G; Van Hilten JJ; Hu MT; Jeon B; Klein C; Leentjens AFG; Mollenhauer B; Postuma RB; Rodríguez-Violante M; Simuni T; Weintraub D; Lawton M; Mestre TA, 2024, 'Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose-Driven Approach', Movement Disorders, 39, pp. 462 - 471, http://dx.doi.org/10.1002/mds.29708

de Boer SCM; Riedl L; Fenoglio C; Rue I; Landin-Romero R; Matis S; Chatterton Z; Galimberti D; Halliday G; Diehl-Schmid J; Piguet O; Pijnenburg YAL; Ducharme S, 2024, 'Rationale and Design of the “DIagnostic and Prognostic Precision Algorithm for behavioral variant Frontotemporal Dementia” (DIPPA-FTD) Study: A Study Aiming to Distinguish Early Stage Sporadic FTD from Late-Onset Primary Psychiatric Disorders', Journal of Alzheimer's Disease, 97, pp. 963 - 973, http://dx.doi.org/10.3233/JAD-230829

Devenney EM; Tse NY; O’Callaghan C; Kumfor F; Ahmed RM; Caga J; Hazelton JL; Carrick J; Halliday GM; Piguet O; Kiernan MC; Hodges JR, 2024, 'An attentional and working memory theory of hallucination vulnerability in frontotemporal dementia', Brain Communications, 6, http://dx.doi.org/10.1093/braincomms/fcae123

Kovacs GG; Grinberg LT; Halliday G; Alafuzoff I; Dugger BN; Murayama S; Forrest SL; Martinez-Valbuena I; Tanaka H; Kon T; Yoshida K; Jaunmuktane Z; Spina S; Nelson PT; Gentleman S; Alegre-Abarrategui J; Serrano GE; Paes VR; Takao M; Wakabayashi K; Uchihara T; Yoshida M; Saito Y; Kofler J; Rodriguez RD; Gelpi E; Attems J; Crary JF; Seeley WW; Duda JE; Keene CD; Woulfe J; Munoz D; Smith C; Lee EB; Neumann M; White CL; McKee AC; Thal DR; Jellinger K; Ghetti B; Mackenzie IRA; Dickson DW; Beach TG, 2024, 'Biomarker-Based Approach to α-Synucleinopathies: Lessons from Neuropathology', Movement Disorders, http://dx.doi.org/10.1002/mds.30028

Kavanagh T; Balcomb K; Ahmadi Rastegar D; Lourenco GF; Wisniewski T; Halliday G; Drummond E, 2024, 'hnRNP A1, hnRNP A2B1, and hnRNP K are dysregulated in tauopathies, but do not colocalize with tau pathology', Brain Pathology, http://dx.doi.org/10.1111/bpa.13305

Yang Y; Kim WS; Michaelian JC; Lewis SJG; Phillips CL; D'Rozario AL; Chatterjee P; Martins RN; Grunstein R; Halliday GM; Naismith SL, 2024, 'Predicting neurodegeneration from sleep related biofluid changes', Neurobiology of Disease, 190, http://dx.doi.org/10.1016/j.nbd.2023.106369

Guennewig B; Lim J; Marshall L; McCorkindale AN; Paasila PJ; Patrick E; Kril JJ; Halliday GM; Cooper AA; Sutherland GT, 2023, 'Author Correction: Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology (Scientific Reports, (2021), 11, 1, (4865), 10.1038/s41598-021-83872-z)', Scientific Reports, 13, http://dx.doi.org/10.1038/s41598-023-36807-9

Marian OC; Teo JD; Lee JY; Song H; Kwok JB; Landin-Romero R; Halliday G; Don AS, 2023, 'Disrupted myelin lipid metabolism differentiates frontotemporal dementia caused by GRN and C9orf72 gene mutations', Acta Neuropathologica Communications, 11, http://dx.doi.org/10.1186/s40478-023-01544-7

Lok HC; Katzeff JS; Hodges JR; Piguet O; Fu YH; Halliday GM; Kim WS, 2023, 'Elevated GRO-α and IL-18 in serum and brain implicate the NLRP3 inflammasome in frontotemporal dementia', Scientific Reports, 13, http://dx.doi.org/10.1038/s41598-023-35945-4

Youssef P; Hughes L; Kim WS; Halliday GM; Lewis SJG; Cooper A; Dzamko N, 2023, 'Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting', Scientific Reports, 13, http://dx.doi.org/10.1038/s41598-023-32480-0

Pavan C; Jin J; Jong S; Strbenac D; Davis RL; Sue CM; Johnston J; Lynch T; Halliday G; Kirik D; Parish CL; Thompson LH; Ovchinnikov DA, 2023, 'Generation of the iPSC line FINi002-A from a male Parkinson's disease patient carrying compound heterozygous mutations in the PRKN gene', Stem Cell Research, 73, http://dx.doi.org/10.1016/j.scr.2023.103211

Tan RH; McCann H; Shepherd CE; Pinkerton M; Mazumder S; Devenney EM; Adler GL; Rowe DB; Kril J; Halliday GM; Kiernan MC, 2023, 'Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis', Acta Neuropathologica Communications, 11, http://dx.doi.org/10.1186/s40478-023-01670-2

Chatterton Z; Lamichhane P; Ahmadi Rastegar D; Fitzpatrick L; Lebhar H; Marquis C; Halliday G; Kwok JB, 2023, 'Single-cell DNA methylation sequencing by combinatorial indexing and enzymatic DNA methylation conversion', Cell and Bioscience, 13, http://dx.doi.org/10.1186/s13578-022-00938-9

Kiernan MC; Halliday GM; Rowe DB; Tan RH, 2023, 'The importance of patient-centred drug development for amyotrophic lateral sclerosis', Neuropathology and Applied Neurobiology, 49, http://dx.doi.org/10.1111/nan.12944

Shepherd CE; Lewis SJG; Tisch S; Mccann H; Jonker B; Halliday GM, 2023, 'Effects of STN/SNr deep brain stimulation in a case of progressive supranuclear palsy with a Parkinson disease phenotype', Journal of Neuropathology and Experimental Neurology, 82, pp. 821 - 823, http://dx.doi.org/10.1093/jnen/nlad052

Pinkerton M; Lourenco G; Pacheco MT; Halliday GM; Kiernan MC; Tan RH, 2023, 'Survival in sporadic ALS is associated with lower p62 burden in the spinal cord', Journal of Neuropathology and Experimental Neurology, 82, pp. 769 - 773, http://dx.doi.org/10.1093/jnen/nlad051

Qi R; Sammler E; Gonzalez-Hunt CP; Barraza I; Pena N; Rouanet JP; Naaldijk Y; Goodson S; Fuzzati M; Blandini F; Erickson KI; Weinstein AM; Lutz MW; Kwok JB; Halliday GM; Dzamko N; Padmanabhan S; Alcalay RN; Waters C; Hogarth P; Simuni T; Smith D; Marras C; Tonelli F; Alessi DR; West AB; Shiva S; Hilfiker S; Sanders LH, 2023, 'A blood-based marker of mitochondrial DNA damage in Parkinson's disease', Science Translational Medicine, 15, http://dx.doi.org/10.1126/SCITRANSLMED.ABO1557

Affleck AJ; Sachdev PS; Halliday GM, 2023, 'Past antihypertensive medication use is associated with lower levels of small vessel disease and lower Aβ plaque stage in the brains of older individuals', Neuropathology and Applied Neurobiology, 49, pp. e12922, http://dx.doi.org/10.1111/nan.12922

Yang Y; Rowe D; McCann H; Shepherd CE; Kril JJ; Kiernan MC; Halliday GM; Tan RH, 2023, 'Treatment with the copper compound CuATSM has no significant effect on motor neuronal pathology in patients with ALS', Neuropathology and Applied Neurobiology, 49, http://dx.doi.org/10.1111/nan.12919

Henden L; Fearnley LG; Grima N; McCann EP; Dobson-Stone C; Fitzpatrick L; Friend K; Hobson L; Moi Fat SC; Rowe DB; D Silva S; Kwok JB; Halliday GM; Kiernan MC; Mazumder S; Timmins HC; Zoing M; Pamphlett R; Adams L; Bahlo M; Blair IP; Williams KL, 2023, 'Short tandem repeat expansions in sporadic amyotrophic lateral sclerosis and frontotemporal dementia', Science Advances, 9, http://dx.doi.org/10.1126/sciadv.ade2044

Ge YJ; Ou YN; Deng YT; Wu BS; Yang L; Zhang YR; Chen SD; Huang YY; Dong Q; Tan L; Yu JT; Ferrari R; Hernandez DG; Nalls MA; Rohrer JD; Ramasamy A; Kwok JBJ; Dobson-Stone C; Brooks WS; Schofield PR; Halliday GM; Hodges JR; Piguet O; Bartley L; Thompson E; Haan E; Hernández I; Ruiz A; Boada M; Borroni B; Padovani A; Cruchaga C; Cairns NJ; Benussi L; Binetti G; Ghidoni R; Forloni G; Galimberti D; Fenoglio C; Serpente M; Scarpini E; Clarimón J; Lleó A; Blesa R; Waldö ML; Nilsson K; Nilsson C; Mackenzie IRA; Hsiung GYR; Mann DMA; Grafman J; Morris CM; Attems J; Griffiths TD; McKeith IG; Thomas AJ; Pietrini P; Huey ED; Wassermann EM; Baborie A; Jaros E; Tierney MC; Pastor P; Razquin C; Ortega-Cubero S; Alonso E; Perneczky R; Diehl-Schmid J; Alexopoulos P; Kurz A; Rainero I; Rubino E; Pinessi L; Rogaeva E; St. George-Hyslop P; Rossi G; Tagliavini F; Giaccone G; Rowe JB; Schlachetzki JCM; Uphill J; Collinge J; Mead S; Danek A; Van Deerlin VM; Grossman M; Trojanowski JQ; van der Zee J; Deschamps W; Van Langenhove T; Cruts M; Van Broeckhoven C; Cappa SF; Le Ber I; Hannequin D; Golfier V; Vercelletto M; Brice A; Nacmias B; Sorbi S, 2023, 'Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood', Biological Psychiatry, 93, pp. 770 - 779, http://dx.doi.org/10.1016/j.biopsych.2022.11.002

Forrest SL; Kim JH; Crockford DR; Huynh K; Cheong R; Knott S; Kane MA; Ittner LM; Halliday GM; Kril JJ, 2023, 'Distribution Patterns of Astrocyte Populations in the Human Cortex', Neurochemical Research, 48, pp. 1222 - 1232, http://dx.doi.org/10.1007/s11064-022-03700-2

Mazumder S; Mccann H; D'silva S; Furlong S; Shepherd CE; Kril JJ; Halliday GM; Rowe DB; Kiernan MC; Tan RH, 2023, 'Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis', Brain, 146, pp. E17 - E19, http://dx.doi.org/10.1093/brain/awac467

Hsiao JHT; Tanglay O; Li AA; Strobbe AYG; Kim WS; Halliday GM; Fu YH, 2023, 'Role of Oligodendrocyte Lineage Cells in Multiple System Atrophy', Cells, 12, http://dx.doi.org/10.3390/cells12050739

Nelson PT; Lee EB; Cykowski MD; Alafuzoff I; Arfanakis K; Attems J; Brayne C; Corrada MM; Dugger BN; Flanagan ME; Ghetti B; Grinberg LT; Grossman M; Grothe MJ; Halliday GM; Hasegawa M; Hokkanen SRK; Hunter S; Jellinger K; Kawas CH; Keene CD; Kouri N; Kovacs GG; Leverenz JB; Latimer CS; Mackenzie IR; Mao Q; McAleese KE; Merrick R; Montine TJ; Murray ME; Myllykangas L; Nag S; Neltner JH; Newell KL; Rissman RA; Saito Y; Sajjadi SA; Schwetye KE; Teich AF; Thal DR; Tomé SO; Troncoso JC; Wang SHJ; White CL; Wisniewski T; Yang HS; Schneider JA; Dickson DW; Neumann M, 2023, 'LATE-NC staging in routine neuropathologic diagnosis: an update', Acta Neuropathologica, 145, pp. 159 - 173, http://dx.doi.org/10.1007/s00401-022-02524-2

Fu YH; Zhou L; Li H; Hsiao J; Li B; Tanglay O; Auwyang AD; Wang E; Feng J; Kim WS; Liu J; Halliday GM, 2023, 'Correction to: Adaptive structural changes in the motor cortex and white matter in Parkinson’s disease (Acta Neuropathologica, (2022), 144, 5, (861-879), 10.1007/s00401-022-02488-3)', Acta Neuropathologica, 145, pp. 157, http://dx.doi.org/10.1007/s00401-022-02523-3

Tse NY; Bocchetta M; Todd EG; Devenney EM; Tu S; Caga J; Hodges JR; Halliday GM; Irish M; Kiernan MC; Piguet O; Rohrer JD; Ahmed RM, 2023, 'Distinct hypothalamic involvement in the amyotrophic lateral sclerosis-frontotemporal dementia spectrum', NeuroImage: Clinical, 37, http://dx.doi.org/10.1016/j.nicl.2022.103281

Labrador-Garrido A; Zhong S; Hughes L; Keshiya S; Kim WS; Halliday GM; Dzamko N, 2023, 'Live cell in situ lysosomal GCase activity correlates to alpha-synuclein levels in human differentiated neurons with LRRK2 and GBA1 mutations', Frontiers in Cellular Neuroscience, 17, http://dx.doi.org/10.3389/fncel.2023.1229213

Phan K; He Y; Bhatia S; Pickford R; Mcdonald G; Mazumder S; Timmins HC; Hodges JR; Piguet O; Dzamko N; Halliday GM; Kiernan MC; Kim WS, 2023, 'Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis', Brain Communications, 5, http://dx.doi.org/10.1093/braincomms/fcac340

Hwang YT; Halliday GM; Piguet O; Burrell JR, 2023, 'Assessing utility of imaging based biomarker to differentiate pathologically classified frontotemporal lobar degeneration syndromes', Alzheimer's & Dementia, 19, http://dx.doi.org/10.1002/alz.075559

McCann H; Halliday GM; Shepherd CE, 2023, 'The relationship between traumatic brain injury and the neuropathology of dementia', Alzheimer's & Dementia, 19, http://dx.doi.org/10.1002/alz.061668

Fumagalli GG; Sorrentino F; de Boer SCM; Riedl L; Landin‐Romero R; Matis S; Southwood D; Chatterton Z; Diehl‐Schmid J; Halliday GM; Ducharme S; Piguet O; Pijnenburg YAL; Galimberti D, 2023, 'Visual rating scales of atrophy to differentiate Frontotemporal dementia from Primary psychiatric disorder: results from DIPPA study', Alzheimer's & Dementia, 19, http://dx.doi.org/10.1002/alz.073286

Fumagalli GG; Sorrentino F; de Boer SCM; Riedl L; Landin‐Romero R; Matis S; Southwood D; Chatterton Z; Diehl‐Schmid J; Halliday GM; Ducharme S; Piguet O; Pijnenburg YAL; Galimberti D, 2023, 'Visual rating scales of atrophy to differentiate Frontotemporal dementia from Primary psychiatric disorder: results from DIPPA study', Alzheimer's & Dementia, 19, http://dx.doi.org/10.1002/alz.081607

Matar E; Ehgoetz Martens KA; Phillips JR; Wainstein G; Halliday GM; Lewis SJG; Shine JM, 2022, 'Dynamic network impairments underlie cognitive fluctuations in Lewy body dementia', npj Parkinson's Disease, 8, http://dx.doi.org/10.1038/s41531-022-00279-x

Ahmadi Rastegar D; Hughes LP; Perera G; Keshiya S; Zhong S; Gao J; Halliday GM; Schüle B; Dzamko N, 2022, 'Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages', npj Parkinson's Disease, 8, http://dx.doi.org/10.1038/s41531-022-00297-9

Back to profile page